Baseret på overlappet i clearenceintervallerne, berettiger den kønsbaserede forskel i farmakokinetik ikke en anbefaling for brug af lavere dosis til kvinder.
Based upon the overlap in the range of clearance, gender-based pharmacokinetic differences do not justify the recommendation for using a lower dose for female patients.